{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:18:51Z","timestamp":1770909531051,"version":"3.50.1"},"reference-count":10,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,7,10]],"date-time":"2007-07-10T00:00:00Z","timestamp":1184025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2008,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> The need and frequency of hepatic biopsies during methotrexate (MTX) therapy are still controversial.<\/jats:p><jats:p><jats:bold>Objectives\u2002<\/jats:bold> The purpose of this investigation is to assess MTX liver toxicity in patients with psoriasis through percutaneous liver biopsy, and compare liver morphology changes with increasing cumulative dosages (1, 2, 3 and 4\u00a0g) of MTX.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Cumulative dosages of 1 to 2\u00a0g MTX did not cause significant liver toxicity. From a cumulative dosage of 3 to 4\u00a0g, there is fibrosis formation, inflammation enhancement in the portal area and fibrous septa, configuring regenerative nodes.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> In patients with no risk factors for liver disease, with normal physical examination and liver tests, biopsy can be done after a cumulative MTX dosage of approximately 1 to 1.5\u00a0g and repeated for each gram. In patients with risk factors, liver biopsy should be done before use of MTX, or within the first 2 months of treatment at the most, and repeated for each gram of cumulative dosage.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2007.02322.x","type":"journal-article","created":{"date-parts":[[2007,7,10]],"date-time":"2007-07-10T07:12:58Z","timestamp":1184051578000},"page":"25-29","source":"Crossref","is-referenced-by-count":13,"title":["Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages"],"prefix":"10.1111","volume":"22","author":[{"given":"SC","family":"Carneiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FF","family":"C\u00e1ssia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Lamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VLA","family":"Chagas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Ramos\u2010e\u2010Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,12,20]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1980.tb06553.x"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1159\/000248822"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1159\/000246408"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1972.01620060005001"},{"key":"e_1_2_7_6_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archderm.1973.01620220007001","article-title":"Methotrexate therapy for psoriasis: guidelines revisions","volume":"108","author":"Roenigk HH","year":"1973","journal-title":"Arch Dermatol"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(88)80237-8"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2004.06.013"},{"key":"e_1_2_7_9_2","first-page":"456","volume-title":"Medical Immunology","author":"Sack KE","year":"1997"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000198155"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.117047"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2007.02322.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2007.02322.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T06:31:41Z","timestamp":1697005901000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2007.02322.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,20]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["10.1111\/j.1468-3083.2007.02322.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2007.02322.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,20]]}}}